Results 81 to 90 of about 5,177,357 (230)
Background: Primary sclerosing cholangitis is a rare and progressive cholestatic disease characterized by narrowing of the biliary tract. Despite high levels of ulcerative colitis, early diagnosis of primary sclerosing cholangitis before the diagnosis of
Somaieh Matin +2 more
doaj
The management of primary sclerosing cholangitis.
Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by a progressive, obliterating fibrosis of the intrahepatic and extrahepatic bile ducts.
Stephen A. Mitchell, Roger W.G. Chapman
core +1 more source
Primary sclerosing cholangitis: diagnostic and management challenges
Sanjeev Sirpal,1 Natasha Chandok2 1Department of Medicine, Centre Hospitalier de l’Université de Montréal (CHUM), University of Montreal, Montreal, QC, 2Department of Medicine, University of Western Ontario, London, ON, Canada ...
Sirpal S, Chandok N
core
Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley +1 more source
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
The aetiology of primary sclerosing cholangitis is unknown, but it is closely associated with ulcerative colitis. Serum anticolon antibodies, crossreacting with portal tracts, have been reported in patients with ulcerative colitis but no studies have ...
W S Selby +5 more
core +1 more source
Primary Sclerosing Cholangitis Multiple Phenotypes, Multiple Approaches [PDF]
Primary sclerosing cholangitis (PSC) is a heterogeneous, idiopathic, inflammatory disorder frequently associated with inflammatory bowel diseases. PSC patients may be classified into several subphenotypes.
Sarkar, Souvik, Bowlus, Christopher L
core +1 more source
Impact of Single Viable Hepatocellular Carcinoma ≤ 3 cm on Survival After Liver Transplantation
An Australian multi‐centre cohort study shows significantly lower 5‐year HCC‐specific mortality for those with no viable disease compared to those with a single viable tumour ≤ 3 cm, on imaging prior to transplantation. A lower AFP level and complete response on mRECIST criteria also reduced risk.
Lauren C. Y. Tang +12 more
wiley +1 more source
PURPOSE OF REVIEW: Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by strictures of the biliary tree. It is immune mediated, although the precise cause remains unknown. Recent reports have shown a higher prevalence and
Chapman, Roger +10 more
core +1 more source
DHOPE‐PRO enabled daytime liver transplantation with comparable one‐year transplantation‐related costs versus short‐duration DHOPE. Higher perfusion costs were offset by lower surgery‐related costs, suggesting DHOPE‐PRO can improve scheduling logistics without increasing overall hospital costs.
Linda C. Woltjes +47 more
wiley +1 more source
In a patient‐reported cohort of 565 adults with autoimmune hepatitis, 96.6% reported corticosteroid‐related side effects within 6 months and long‐term toxicity increased with cumulative exposure. The findings support earlier tapering, toxicity monitoring, lower induction dosing when appropriate and selective budesonide use in carefully chosen non ...
Elizabeth Gentry +4 more
wiley +1 more source

